Objective: The purpose of this research was to study the clinical efficacy of Fuxin decoction in the treatment of heart failure

and provide the reference basis for the future clinical treatment. Method: One hundred and twenty patients with heart failure cured in our hospital from Feb 2012 to Dec 2013 were randomized into the control group (treated with the routine anti-heart failure therapy such as strong heart and dieresis) and the observation group (Fuxin decoction added based on the control group)

with 60 patients per group. The efficacy of heart function

traditional Chinese medicine(TCM) syndrome scores

adverse reactions

left ventricular end diastolic diameter (LVEDD)

left ventricular ejection fraction (LVEF) and E/A value on pre-and post-treatment in the two groups were observed and compared. Result: compared with the control group

the heart function efficacy (96.7% vs 86.7%) and the TCM syndrome scores efficacy (91.7% vs 73.3%)were significantly increased

the incidence of adverse reactions was obviously reduced (1.7% vs 13.3%)in the observation group

P<0.05;compared with the control group

the LVEF(47.0±1.0 vs 44.4±1.2)and E/A values (1.3±0.4 vs 1.0±0.3)were significantly increased in the post-treatment in the observation group

P<0.05. Conclusion: The efficacy of Fuxin decoction in the treatment of heart failure is significant

it can improve the patient's heart function and prognosis quality with less adverse reactions and higher treatment safety

which is worthy of clinical promotion.